Larisa Belyanskaya - Concepedia

Author

Larisa Belyanskaya

Also Known As

L Belyanskaya, L. Belyanskaya, L. L. Belyanskaya, L.L. Belyanskaya, Larisa Belyanskaya, Larisa L Belyanskaya, Larisa L. Belyanskaya

Publications

1.1K

Citations

H-Index

Concepts

All Affiliations

Octapharma (Switzerland)University Hospital of Zurich University of Zurich Russian Children's Clinical Hospital Octapharma (Austria)

About

Larisa Belyanskaya is an author at Octapharma (Switzerland) specializing in medicine, cell biology, and tumor biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	339
2	Engineering	1	1	190
3	Health Sciences	1	1	27
4	Social Sciences	1	1	185
5	Allergy	1	1	27

Larisa Belyanskaya

Publications

Citations

H-Index

Page 1

	Year	Citations
The reliability and limits of the MTT reduction assay for carbon nanotubes–cell interaction Larisa Belyanskaya, Pius Manser, Philipp Spohn, Carbon EngineeringCarbon Nanotubes–cell InteractionCarbon-based MaterialNanomaterialsNanotechnology	2007	190
Effects of carbon nanotubes on primary neurons and glial cells Larisa Belyanskaya, Stefan Weigel, Cordula Hirsch, NeuroToxicology Carbon-based MaterialNeurophysiologyCarbon NanotubesNeuroscienceCell Biology	2009	185
Cisplatin activates Akt in small cell lung cancer cells and attenuates apoptosis by survivin upregulation Larisa Belyanskaya, Sally Hopkins‐Donaldson, Stefanie Kurtz, International Journal of Cancer	2005	102
Exposure on Cell Surface and Extensive Arginine Methylation of Ewing Sarcoma (EWS) Protein Larisa Belyanskaya, Peter Gehrig, Heinz Gehring Journal of Biological Chemistry	2001	89
Human agonistic TRAIL receptor antibodies Mapatumumab and Lexatumumab induce apoptosis in malignant mesothelioma and act synergistically with cisplatin Larisa Belyanskaya, Thomas M. Marti, Sally Hopkins-Donaldson, Molecular Cancer	2007	66
First prospective report on immune tolerance in poor risk haemophilia A inhibitor patients with a single factor VIII/von Willebrand factor concentrate in an observational immune tolerance induction study W. Kreuz, Carmen Escuriola Ettingshausen, Vladimír Vdovin, Haemophilia	2015	56
<scp>PK</scp>‐guided personalized prophylaxis with Nuwiq<sup>®</sup> (human‐cl rh<scp>FVIII</scp>) in adults with severe haemophilia A Toshko Lissitchkov, L. Rusen, Pencho Georgiev, Haemophilia	2017	51
TRAIL-induced survival and proliferation of SCLC cells is mediated by ERK and dependent on TRAIL-R2/DR5 expression in the absence of caspase-8 Larisa Belyanskaya, Algirdas Ziogas, Sally Hopkins-Donaldson, Lung Cancer Trail-induced SurvivalSignal TransductionSignaling PathwayCell RegulationSclc Cells	2008	49
Different methylation characteristics of protein arginine methyltransferase 1 and 3 toward the Ewing Sarcoma protein and a peptide Steffen Pahlich, Karim Bschir, Claudio Chiavi, Proteins Structure Function and Bioinformatics	2005	40
Expression and subcellular localization of Ewing sarcoma (EWS) protein is affected by the methylation process Larisa Belyanskaya Experimental Cell Research Cancer ResearchEwing SarcomaMethylation ProcessSubcellular LocalizationPathology	2003	36

Page 1